Literature DB >> 22521304

Conditioning the whole heart--not just the cardiomyocyte.

Robert M Bell1, Derek M Yellon.   

Abstract

Conditioning, the recruitment of endogenous cytoprotective pathways that protect the myocardium against injurious ischaemia/reperfusion injury, has developed into a range of modalities that can be applied before (preconditioning), during (perconditioning) or after the injurious ischaemic insult (postconditioning), either directly to the heart or in a distal tissue (remote preconditioning). A wide range of triggers, signaling pathways and potential end-effector mechanisms have been identified, which appear common to all forms of conditioning. Interestingly, conditioning applies to not only the cardiac myocyte, but to all the constitutive cell types within the myocardium. As our understanding of conditioning mechanisms continue to develop and we start to realise some of the difficulties in translating these phenomena to clinical treatments, it may be time to take a more integrative approach to conditioning, considering the many cellular and tissue types within the heart, and how they contribute to cytoprotective adaptations. In this review, we shall look at the conditioning phenomena, how different cell types contribute to the conditioned phenotype, and where novel cardioprotective modalities may be developed.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22521304     DOI: 10.1016/j.yjmcc.2012.04.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  20 in total

Review 1.  Current Modalities and Mechanisms Underlying Cardioprotection by Ischemic Conditioning.

Authors:  John H Rosenberg; John H Werner; Michael J Moulton; Devendra K Agrawal
Journal:  J Cardiovasc Transl Res       Date:  2018-05-24       Impact factor: 4.132

2.  Perivascular tissue inhibits rho-kinase-dependent smooth muscle Ca(2+) sensitivity and endothelium-dependent H2 S signalling in rat coronary arteries.

Authors:  Filip Aalbaek; Lisbeth Bonde; Sukhan Kim; Ebbe Boedtkjer
Journal:  J Physiol       Date:  2015-10-07       Impact factor: 5.182

Review 3.  The pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondria.

Authors:  L Maximilian Buja
Journal:  Tex Heart Inst J       Date:  2013

4.  Protection from oxidative and electrophilic stress in the Gsta4-null mouse heart.

Authors:  Helen Beneš; Mai K Vuong; Marjan Boerma; Kevin E McElhanon; Eric R Siegel; Sharda P Singh
Journal:  Cardiovasc Toxicol       Date:  2013-12       Impact factor: 3.231

Review 5.  Mitochondrial oxidative metabolism and uncoupling proteins in the failing heart.

Authors:  Alexander T Akhmedov; Vitalyi Rybin; José Marín-García
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

6.  Ischemic postconditioning: mechanisms, comorbidities, and clinical application.

Authors:  Bruno Buchholz; Martín Donato; Verónica D'Annunzio; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2014-03-13       Impact factor: 3.396

Review 7.  Acid-base regulation and sensing: Accelerators and brakes in metabolic regulation of cerebrovascular tone.

Authors:  Ebbe Boedtkjer
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-06       Impact factor: 6.200

8.  Searching myocardial rescue through intermittent upper arm occlusion and lizard saliva.

Authors:  Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2021-01-25       Impact factor: 17.165

Review 9.  Cardiac Mechano-Gated Ion Channels and Arrhythmias.

Authors:  Rémi Peyronnet; Jeanne M Nerbonne; Peter Kohl
Journal:  Circ Res       Date:  2016-01-22       Impact factor: 17.367

10.  Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats.

Authors:  Márta Sárközy; Agnes Zvara; Nóra Gyémánt; Veronika Fekete; Gabriella F Kocsis; Judit Pipis; Gergő Szűcs; Csaba Csonka; László G Puskás; Péter Ferdinandy; Tamás Csont
Journal:  Cardiovasc Diabetol       Date:  2013-01-15       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.